Prosecution Insights
Last updated: July 17, 2026
Application No. 18/319,697

LAUNDRY COMPOSITION COMPRISING SPORES

Non-Final OA §103
Filed
May 18, 2023
Priority
May 19, 2022 — EU 22174452.7
Examiner
HURST, JONATHAN M
Art Unit
1799
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
53%
Grant Probability
Moderate
1-2
OA Rounds
10m
Est. Remaining
72%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
360 granted / 677 resolved
-11.8% vs TC avg
Strong +18% interview lift
Without
With
+18.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
42 currently pending
Career history
711
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
83.0%
+43.0% vs TC avg
§102
3.1%
-36.9% vs TC avg
§112
2.7%
-37.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 677 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I in the reply filed on 12/29/2025 is acknowledged. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-16 are rejected under 35 U.S.C. 103 as being unpatentable over Kandzia et al. (US 2019/0093049) and further in view of Bao et al. (WO 2022/101005). Regarding claim 1 Kandzia discloses a concentrated laundry composition which is dilutable in water to form a liquid laundry detergent composition (See Kandzia Abstract and [0030]-[0031] wherein the composition is a concentrated laundry detergent dilutable in water.) wherein the concentrated composition comprises: a) surfactant; (See Kandzia [0053]-[0068] wherein various surfactants and combinations thereof are utilized.) b) a rheology modifier; and (See Kandzia [0032] and [0081] wherein the composition is changed from solid, gel, liquid, various components must be added which alter rheology of the composition, i.e. a liquid has a different rheology than a solid or a gel. Additionally the agents of [0081] alter rheology to some extent.) c) from about 1x102 to about 1x109 CFU/g of the composition of bacterial spores. (See Kandzia [0024] wherein spores are in the composition at 1x103 to about 1x107 CFU/g.) Kandzia does not specifically disclose the surfactant being provided from about 15-85% by weight of surfactant or specific rheology modifiers. Bao discloses a laundry composition dilutable in water and having a composition being about 15 to about 85% by weight of surfactant; a rheology modifier; and other desirable components. (See Bao Abstract and Pg. 1 Lines 22-33) It would have been obvious to one of ordinary skill in the art at the time of filing to provide the surfactants and rheology modifiers of Bao at the described amounts in the laundry composition of Kandzia because such materials represent effective amounts of laundry detergent additives which result in a detergent that behaves in a more satisfactory manner to the user upon dilution. Regarding claims 2-4 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition comprises Bacillus amyloliquefaciens spores. (See Kandzu Abstract and [0017] wherein the spores are Bacillus amyloliquefaciens spores.) Regarding claim 5 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the surfactant comprises a non-ionic surfactant, an anionic surfactant, or a mixture thereof. (See Kandzi [0052] wherein the surfactant is nonionic of anionic.) Regarding claim 6 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the surfactant comprises an alcohol ethoxylate and an alkylbeneze sulfonate.(See Bao Pg. 4 Line 5-10 and lines 25-27 and Pg. 11 Lines 15-23 wherein the surfactant comprises a mixtures of anionic, i.e. alkylbenzene sulfonate, and non-ionic, i.e. alcohol ethoxylate, components. Regarding claim 7 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition comprises from about 25 to about 55% by weight of surfactant. (See Bao Pg. 4 Lines 5-10 wherein surfactant is 20-50% of the composition.) It would have been obvious to one of ordinary skill in the art at the time of invention to have selected the overlapping portion of the ranges disclosed by the reference because selection of overlapping portion of ranges has been held to be a prima facie case of obviousness. In re Malagari, 182 USPQ 549. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations a prima facie case of obviousness is established. See In re Harris, 409 F.3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Regarding claim 8 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition comprises from about 5 to about 20% by weight of the rheology modifier. (See Bao Pg. 10 and Line 7-10 wherein the rheology modifier is 0.01-8% of the weight of the composition.) It would have been obvious to one of ordinary skill in the art at the time of invention to have selected the overlapping portion of the ranges disclosed by the reference because selection of overlapping portion of ranges has been held to be a prima facie case of obviousness. In re Malagari, 182 USPQ 549. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations a prima facie case of obviousness is established. See In re Harris, 409 F.3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Regarding claim 9 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition further comprises hydrogenated castor oil. (See Bao Pg. 22 Line 10-16 wherein the rheology modifier further comprises hydrogenated castor oil.) Regarding claim 10 modified Kandzia discloses all the claim limitations as set forth above as well as the composition the rheology modifier comprises a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates, or its salts, or a mixture thereof. (See Bao Pg. 8 Lines 1-5 and Pg. 9 Lines 15-27 wherein the rheology modifier includes both a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates.) Modified Kandzia does not specifically disclose the rheology modifier being 5 about to about 10% by weight of the fatty alcohol alkoxylates however it is noted that the cited art recognizes that the amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates is known to be modified according to desired use. As the cost of materials and viscosity are variables that can be modified, among others, by adjusting said relative amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates , with said cost and viscosity both increasing as the relative amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates is increased, the precise relative amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates would have been considered a result effective variable by one having ordinary skill in the art at the time the invention was made. As such, without showing unexpected results, the claimed relative amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates cannot be considered critical. Accordingly, one of ordinary skill in the art at the time the invention was made would have optimized, by routine experimentation, the relative amount of grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates of modified Kandzia to obtain the desired balance between the cost and the viscosity (In re Boesch, 617 F.2d. 272, 205 USPQ 215 (CCPA 1980)), since it has been held that where the general conditions of the claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. (In re Aller, 105 USPQ 223). Regarding claim 11 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the rheology modifier comprises an ethoxylated sorbitan ester. (See Pg. 9 Lines 15-27 wherein the rheology modifier includes ethoxylated sorbitan ester) Regarding claim 12 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the rheology modifier comprises a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates, or its salts, or a mixture thereof, and an ethoxylated sorbitan ester. (See Bao Pg. 8 Lines 1-5 and Pg. 9 Lines 15-27 wherein the rheology modifier includes both a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates and ethoxylated sorbitan ester) Regarding claim 13 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the rheology modifier comprises polyethylene glycol. (See Bao Pg. 9 Line 15 – Pg. 10 Line 15 wherein the rheology modifier comprises PEG) Regarding claim 14 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the rheology modifier comprises a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates, or its salts, or a mixture thereof, and polyethylene glycol. . (See Bao Pg. 8 Lines 1-5 and Pg. 9 Lines 15—Pg. 10 Line 15 wherein the rheology modifier includes both a grafted copolymer of an acrylic polymer and fatty alcohol alkoxylates and PEG) Regarding claim 15 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition further comprises an enzyme.(See Kandzia [0071] wherein the composition comprises an enzyme.) Regarding claim 16 modified Kandzia discloses all the claim limitations as set forth above as well as the composition wherein the composition further comprises an adjunct comprising one or more of: peroxy compounds, bleach activators, anti-redeposition agents, neutralizers, optical brighteners, foam inhibitors, chelators, bittering agents, dye transfer inhibitors, soil release agents, water softeners, electrolytes, pH regulators, anti-graying agents, anti-crease components, bleach agents, colorants, scents, processing aids, and mixtures thereof. (See Kandzia [0079] wherein the composition comprises scents.) Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JONATHAN M HURST whose telephone number is (571)270-7065. The examiner can normally be reached on M-F 7AM-4PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Marcheschi can be reached on 571-272-1374. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JONATHAN M HURST/ Primary Examiner, Art Unit 1799
Read full office action

Prosecution Timeline

May 18, 2023
Application Filed
May 04, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12680063
DEVICES AND METHODS FOR THE GENERATION AND EVALUATION OF ENGINEERED TISSUES
3y 11m to grant Granted Jul 14, 2026
Patent 12668804
BIOSYNTHESIS OF ERIODICTYOL
4y 2m to grant Granted Jun 30, 2026
Patent 12668765
MICROFLUIDIC SYSTEM SIMULATING LUNG TISSUE
3y 9m to grant Granted Jun 30, 2026
Patent 12653180
HYPOTHERMIC TISSUE STORAGE
1y 3m to grant Granted Jun 16, 2026
Patent 12650383
REACTION PROCESSOR
2y 1m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
53%
Grant Probability
72%
With Interview (+18.4%)
4y 0m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 677 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month